Background
==========

Draft sequences of human, mouse, fruit fly, and nematode genomes have recently been released, and the sequencing of several other complex genomes is underway. The next challenge -- sequence completion and verification -- requires the closing of the gaps between contigs, isolation and characterization of centromeric and telomeric regions that are poorly represented in libraries, and verification of contig assembly. These goals could be greatly simplified by a cloning strategy that would allow selective isolation of any genomic region. Driven by the needs of functional genomics, a novel approach for DNA cloning by homologous recombination in *Escherichia coli*has been recently developed \[[@B1],[@B2]\]. While the new approach greatly simplify cloning protocols, peculiarities of *E. coli*transformation do not allow to apply recombinogenic engineering to large size of DNA fragments.

We developed an alternative cloning procedure based on transformation-associated recombination (TAR) in the yeast *Saccharomyces cerevisiae*\[[@B3],[@B4]\]. TAR cloning allows to selectively isolate genomic fragments up to 300 kb. The following two general TAR cloning approaches were developed and exploited \[[@B5],[@B6]\]. (i) When DNA sequence information is available from both the 3\' and 5\' flanking regions of the gene of interest, the gene is isolated using a vector with two short unique sequences that flank the gene. The hooks can be as small as 60 bp \[[@B7]\]. (ii) When DNA sequence information is available only as 3\' or 5\' flanking regions, a modified version of TAR cloning, called radial TAR cloning, is used. In radial TAR cloning, one hook is a unique sequence from the chromosomal region of interest and the other is a repeated sequence that occurs frequently and randomly throughout the genomic DNA (*i.e., Alu*repeats in human DNA and *B1*repeats in mouse DNA). The radial cloning method involves isolation of a set of nested overlapping fragments that extend from the gene-specific targeting hook to upstream or downstream *Alu*(or *B1*) positions in the gene of interest. TAR cloning has been used successfully to isolate over a dozen single copy genes from human and mouse genomes \[\[[@B6]-[@B13]\] and NK, unpublished data\].

TAR cloning requires that the cloned DNA fragment carry at least one autonomously replicating sequence (*ARS*) that can function as the origin of replication in yeast. Sequences that function as *ARS*s in yeast occur on average every 20 to 40 kb in all the eukaryotic genomes thus far examined \[[@B14],[@B15]\], which suggests that most mammalian chromosomal regions can be readily isolated by TAR-cloning with a vector that lacks an *ARS*. The *ARS*frequency in chromosomal regions that consist of multiple repetitive elements, however, such as the centromere and telomere, may be reduced, meaning that these regions may not be isolatable by the original TAR method.

This report describes a general TAR cloning system for isolation of genomic regions regardless of the presence of *ARS*elements. In this new system, the TAR vector contains an *ARS*and a counter-selectable marker. Negative genetic selection eliminates the background due to vector recircularization caused by end-joining during yeast transformation. This novel method provides a powerful tool for structural and functional analysis of eukaryotic and prokaryotic genomes.

Results
=======

Vectors with a counter-selectable marker at the end of a targeting hook are not efficient for gene isolation from complex genomes
---------------------------------------------------------------------------------------------------------------------------------

Isolation of *ARS*-less genomic regions by TAR cloning requires incorporation of yeast origin of replication into the vector. It is well documented, however, that linearized *ARS/CEN*vectors circularize with high efficiency via illegitimate end-joining during yeast transformation \[\[[@B16]\] and references therein\]. To eliminate background resulting from re-circularization of the vector during TAR cloning, we investigated two different strategies based on use of a counter-selectable marker.

The first strategy exploited a vector with a counter-selectable marker placed at the end of one of the targeting hooks. This strategy is similar to one widely used for gene disruption in mice \[[@B17]\] and was recently successful in isolating chromosomal fragments from a prokaryotic genome \[[@B18]\]. To apply the strategy, we constructed a TAR vector which, when linearized, had the structure *URA3-Hook1-CEN6-ARSH4-HIS3-Hook2*. Hook1 and Hook2 represent two targeting sequences, while *URA3*is a marker that can be selected for or against in yeast. Circularization of the vector does not prevent *URA3*expression and, therefore, the clones containing the vector without the DNA insert can not grow on media containing 5-FOA. If the TAR vector recombines with a genomic DNA fragment, the *URA3*gene is lost and the resulting YAC clone becomes resistant to 5-FOA.

We used the selection system described above to isolate the Tg.AC transgene from the mouse genome. The Tg.AC transgenic mouse carries approximately 40 copies of the transgene integrated into a unique site on chromosome 11 \[\[[@B11]\] and references therein\]. Each copy includes the *v-Ha-ras*gene and a simian virus 40 (SV40) polyadenylation signal and is under control of a zeta-globin promoter. The TAR vector used in this experiment, pARS-SV211-URA, contained a 211-bp transgene-specific hook and a *B1*repeat as the second hook (see Methods). The vector was linearized between the *B1*targeting hook and *URA3*and co-transformed with genomic DNA into yeast spheroplasts. Transformants were selected on histidine-minus synthetic medium containing 5-FOA. No transgene-positive clones were found among the 1,000 transformants analyzed. Because the standard TAR cloning technique (i.e., one that uses a vector lacking *ARS*and a counterselectable marker) yields about 1%-2% transgene-positive transformants \[[@B7],[@B15]\], this result demonstrates that the specific targeting hook recombines much less efficiently when it is protected by a \~ 1.1 kb nonhomologous *URA3*sequence. To study in greater detail how the presence of nonhomologous DNA at the end of one of the hooks reduces gene capture efficiency, we constructed a set of TAR vectors with different lengths of nonhomologous DNA next to the hook. Each vector contained a 60-bp transgene-specific hook and a common *B1*repeat as the second hook. Figure [1](#F1){ref-type="fig"} summarizes the results of radial TAR cloning of the transgene with those vectors. As can be seen, the yield of gene-positive clones progressively declined as the length of the nonhomologous DNA increased. Even 37 bp of nonhomologous DNA decreased TAR cloning efficiency \~ 5 times. These results demonstrate that TAR cloning vectors with a counter-selectable marker at the end of one of the hooks are inefficient for cloning the genes from complex mammalian genomes.

![Effect on gene capture of length of nonhomologous sequences placed at the end of the hook. The diagram shows only one of the targeting hooks of the pVC-SV60-polylinker TAR vector. The vector was cut with a set of endonucleases to release the SV40-specific targeting hook with a different length polylinker (**A**). Yield of transgene-positive clones obtained with different TAR constructs (**B**).](1471-2164-4-16-1){#F1}

Rationale for TAR cloning of genomic regions lacking ARS sequences
------------------------------------------------------------------

To reduce the background caused by recircularization of *ARS*-containing vectors, we developed a different gene capture strategy (Figure [2](#F2){ref-type="fig"}). As in the first approach, the TAR vector contained a yeast centromere (*CEN6*), a yeast *ARS*element (*ARSH4*), a positive-selectable marker (*HIS3*), and a negative-selectable marker (*URA3*). In this approach, however, the targeting hooks are placed between the promoter and the open reading frame of the *URA3*gene. The promoter derived from the *S. pombe ADH1*gene exhibits specific spacing requirements for its function such that the permissive distance between the TATA element and the transcription initiation site is at most 130 bp \[[@B19],[@B20]\]. A greater distance results in transcription initiation at an alternative site and inactivation of *URA3*expression. The specific spacing requirements allow selection against the recircularized vector. Figure [2](#F2){ref-type="fig"} shows the outcomes of two different events involving such a TAR vector. In Figure [2A](#F2){ref-type="fig"}, the TAR vector recombines with a genomic DNA fragment via the targeting hooks, which results in separation of the TATA box from the transcription initiation site in the *URA3*gene by the DNA insert. The resulting YAC does not express *URA3*and, therefore, the clone can be selected by medium containg 5-FOA. Figure [2B](#F2){ref-type="fig"} shows the results of nonhomologous end-joining leading to re-circularization of the vector. In this case, the distance between the TATA element and the transcription initiation site is not changed, and *URA3*is expressed normally, rendering the clone sensitive to 5-FOA.

![TAR cloning of genomic regions lacking *ARS*sequences. The TAR vector carries a yeast centromere (*CEN6*), a yeast positive selectable marker (*HIS3*), a negative-selectable marker (*URA3*), and two gene-specific targeting hooks. *URA3*is a hybrid gene containing the open reading frame of the *S. cerevisiae URA3*gene and the promoter of the *S. pombe ADH1*gene. The promoter tolerates the insertion of up to a 130-bp sequence between the TATA box and the transcription initiation site. Further increase of the distance between the TATA box and the transcription initiation site inactivates *URA3*expression. The reason the targeting hooks inserted into the *ADH1*promoter do not disrupt *URA3*expression is that their combined length is less than 130 bp. This configuration allows selection of TAR cloning events against the vector re-circularization. (**A**) Homologous recombination between the gene-specific targeting hooks and the genomic fragment containing the gene of interest leads to insertion of the genomic fragment between the TATA box and the transcription initiation site. Such clones can be selected by their ability to grow on media containing 5-FOA, which abolishes *URA3*expression. (**B**) Nonhomologous end-joining forms a circular vector. The *URA3*marker is normally expressed in these clones, so they do not grow on media containing 5-FOA. (R = resistant, S = sensitive to 5-FOA, DBS = double strand break.)](1471-2164-4-16-2){#F2}

Isolation of specific chromosomal regions with a TAR vector containing ARS and a counter-selectable marker
----------------------------------------------------------------------------------------------------------

We used the TAR cloning strategy described above to isolate the *v-Ha-ras*Tg.Ac transgene region from mouse DNA. The vector pARS-TGAC contained 60 bp of SV40 as a transgene-specific targeting hook and 50 bp of a common mouse repeat *B1*as a second hook. Both selected targeting sequences do not contain an ATG initiation codon that is out-of-frame with the vector *URA3*, which avoids the translational incompetence of *URA3*mRNA and resistance to 5-FOA (see Methods). The targeting hooks were placed in the promoter region of *URA3*as shown in Figure [2](#F2){ref-type="fig"}. Genomic DNA and the linearized TAR cloning vector were combined with yeast spheroplasts and the His^+^Ura^-^transformants were selected on medium containing 5-FOA to identify clones with genomic DNA inserts. Yield of the transformants varied from 100 to 300 colonies/ug vector, 2 ug genomic DNA, and 2 × 10^8^spheroplasts (Table [3](#T3){ref-type="table"}). Eight transgene-positive YAC clones were identified among 950 His^+^5-FOA-resistant transformants screened by PCR for the presence of the zeta-globin promoter sequence (Table [3](#T3){ref-type="table"}). Among 8 YAC clones characterized by CHEF electrophoresis, size of inserts varied from 50 to 200 kb. Approximately the same yield of gene-positive clones had been previously observed during TAR cloning of this genomic region with vectors lacking *ARS*and a counter-selectable marker \[[@B7],[@B15]\]. No transgene-positive clones were found when 5-FOA selection was omitted (Table [3](#T3){ref-type="table"}), indicating that the new TAR cloning method is highly selective and efficient for isolation of multicopy genes.

###### 

TAR vectors used in this study

  **Plasmid**           ***ARS*presence**   **Hook 1**          **Hook 2**          **Linearization site**
  --------------------- ------------------- ------------------- ------------------- ------------------------------------------
  pARS-TGAC             \+                  60 bp SV40          50 bp *B1*          *Sal*I
  pARS-HPRT             \+                  56 bp 5\' *HPRT*    60 bp 3\' *HPRT*    *Sal*I
  pARS-ALF              \+                  40 bp alphoid DNA   40 bp alphoid DNA   *Mlu*I
  pARS-Alu90            \+                  45 bp *Alu*         45 bp *Alu*         *Sma*I
  pARS-Alu110           \+                  45 bp *Alu*         65 bp *Alu*         *Sma*I
  pARS-Alu120           \+                  45 bp *Alu*         75 bp *Alu*         *Sma*I
  pARS-Alu130           \+                  65 bp *Alu*         65 bp *Alu*         *Sma*I
  pARS-Alu150           \+                  75 bp *Alu*         75 bp *Alu*         *Sma*I
  pARS-Alu190           \+                  115 bp *Alu*        75 bp *Alu*         *Sma*I
  pARS-SV211-URA        \+                  211 bp SV40         130 bp *B1*         *Bam*HI
  pVC-SV211             \-                  211 bp SV40         130 bp *B1*         *Bam*HI
  pVC-SV60              \-                  60 bp SV40          130 bp *B1*         *Sal*I
  pVC-SV60-polylinker   \-                  60 bp SV40          130 bp *B1*         *Sal*I, *Eco*RI, *Bam*HI, *Sma*I, *Not*I

###### 

Primers used in this study

  Primer          Sequence                                                                      Restriction site
  --------------- ----------------------------------------------------------------------------- ------------------
  **Group A\***                                                                                 
  ADH-F           5\'-atgc**gggccc**CCTACAACAACTAAGAAAATGGC-3\'                                 *Apa*1
  ADH-R           5\'-atgcatgc**ctcgag**CCACTATTTATACCATGGGAGG-3\'                              *Xho*1
  URA-ARS-F       5\'-atgc**atcgat**GTCGAAAGTTACATATAAGGAACGT-3\'                               *Cla*1
  URA-ARS-R       5\'-atgc**ggatcc**CAGTTTTTTAGTTTTGCTGGCCGC-3\'                                *Bam*H1
  alu45-F         5\'-atgc**atcgat**GTCCCAGCTACTTGGGAGGC-3\'                                    *Cla*1
  alu45-R         5\'-atgcatgc**ctcgag**GGAGTGCAGTGGCGGGATCT-3\'                                *Xho*1
  alu65-F         5\'-atgc**atcgat**CGTAGTGGCGGGCGCCTGTA-3\'                                    *Cla*1
  alu65-R         5\'-atgcatgc**ctcgag**TCTCGCTCTGTCGCCCAGGC-3\'                                *Xho*1
  alu75-F         5\'-atgc**atcgat**ATTAGCCGGGCGTAGTGGCG-3\'                                    *Cla*1
  alu75-R         5\'-atgcatgc**ctcgag**GAGACGGAGTCTCGCTCTGT-3\'                                *Xho*1
  alu190-F        5\'-atgc**atcgat**CTAAAACGGTGAAACCCCGT-3\'                                    *Cla*1
  SV-ARS-F        5\'-atgc**atcgat**TTATACACTTAAAAATTTTA-3\'                                    *Cla1*
  SV-ARS-R        5\'-atgcatgc**ctcgag**CTGCCTCCCAAGTGCTGGGATTAAAGGCGTGCGCCACC**t**TGCCCG-3\'   *Xho*1
  HP-ARS-F1       5\'-atgcatgc**ctcgag**CCTCGGCTTCTTCTGGGA-3\'                                  *Xho*1
  HP-ARS-R1       5\' atgcatgc**gtcgac**GTTTGCAGGCTCACTAGGTAG 3\'                               *SalI*
  HP-ARS-F2       5\' atgcatgc**gtcgac**GTAGGATATGCCCTTGACTAT 3\'                               *SalI*
  HP-ARS-R2       5\'-atgc**atcgat**GAAGCAATTACTTACATTCAA-3\'                                   *Cla*1
  ALF-F           5\'-atgc**atcgat**AAGAGTGTTTCAAAACTGCT-3\'                                    *Cla*1
  ALF-R           5\'-atgcatgc**ctcgag**CATTCTCAGAAACTTCTTTGTGA[**a**]{.ul}GTTTGC-3\'           *Xho*1
  **Group B\***                                                                                 
  ALU-DET-F       5\'-GGCCGGGCGCGGTGGCTCACGCCTGTAA-3\'                                          
  ALU-DET-R       5\'-TGTATTTTTAGTAGAGACGGG-3\'                                                 
  Y-SAT-F         5\'-GAATCTGCAAGTGGATATTTG-3\'                                                 
  Y-SAT-R         5\'-TCTGTGAGATGAATGCACACA-3\'                                                 

Upper case letters indicate homologous regions. Lower case letters indicate nonhomoloqous sequences. Bold letters indicate endonuclease restriction sites used for cloning PCR products. Underlined lower case letters indicate nucleotide substitutions introduced into the primer to eliminate an out-of-frame ATG initiation codon in the targeting hook. \*Group A includes primers used for plasmid construction; group B includes primers used for *Alu*- and *Sat*-probes.

We also tested whether TAR cloning with an *ARS*-containing vector and negative selection can be used to isolate a single copy gene from a complex genome, such as *HPRT*from the human genome. We designed a TAR cloning vector pARS-HPRT carrying a 56-bp 5\' *HPRT*-specific targeting hook and a 60-bp 3\' *HPRT*-specific hook and inserted them into the promoter region of *URA3*(see Methods). His^+^Ura^-^transformants were selected on medium containing 5-FOA to identify recombinant clones. Transformant yields ranged from 20 to 70 colonies (Table [3](#T3){ref-type="table"}). A low yield is predicted for a TAR vector containing two unique targeting hooks. We screened 625 randomly picked transformants by PCR for the presence of *HPRT*, and 3 (\~ 0.5%) of them carried all the *HPRT*exon sequences (Table [3](#T3){ref-type="table"}). All gene-positive clones contained circular YACs with \~ 40 kb DNA inserts (data not shown). Such a high yield of *HPRT*-positive clones has been previously observed with a similar vector lacking the *ARS*element \[[@B15]\]. Our results indicate that the novel TAR cloning system is highly efficient, highly selective, and sufficiently sensitive to isolate a single copy gene from the large and complex genomes.

Selective isolation of centromeric regions
------------------------------------------

The new TAR cloning system is useful for isolation of heterochromatic regions enriched by repeats and presumably poor in *ARS*elements, such as a mammalian centromere. Human centromeres contain primarily alpha (or alphoid) satellite DNA. Alphoid DNA consists of 171-bp repeating units organized into higher order repeats. The length of centromeric alphoid arrays of different human chromosomes varies from 0.2 to 5 Mb.

To apply the new selection strategy for isolation of large blocks of alphoid DNA, we created a TAR vector pARS-ALF with the structure *SAT-pADH1-CEN6-ARSH4-HIS3-URA3-SAT*, where *SAT*represents two 40-bp fragments from the alphoid DNA consensus sequence (see Methods). As in the constructs described above, the targeting hooks were inserted into the *URA3*promoter region. TAR cloning of human centromeric DNA was carried out as described above. The average yield of His^+^Ura^-^transformants was 250. To detect the colonies with alphoid DNA inserts, randomly selected transformants were tested by dot-hybridization with an alphoid DNA-specific probe. The probe has no homology to the targeting sequences in the TAR vector (see Methods). Roughly 50% of the clones reacted with the probe, indicating high selectivity of TAR cloning (Fig. [3A](#F3){ref-type="fig"} and Table [4](#T4){ref-type="table"}). Twenty alphoid DNA-positive clones were further characterized. The size of YAC inserts was determined by clamped homogeneous electrical field gel electrophoresis and visualized with an alphoid DNA probe. The size of the YACs varied from 50 kb to 210 kb (Fig. [3B](#F3){ref-type="fig"}). Some isolates had more than one band, suggesting that some satellite sequences may be unstable in yeast cells, as has been previously reported \[[@B21]\]. Alternatively, the transformants may have acquired more than one YAC. The relatively large sizes of the inserts suggest that genomic alphoid DNA fragments recombine with targeting hooks in the vector by sequences located at DNA fragment ends, rather than by internal sequences.

![Characterization of alphoid DNA YACs obtained by an *ARS*-containing TAR vector. (**A**). Detection of alphoid DNA-positive clones by colony hybridization (**B**). CHEF analysis of circular YAC isolates containing alphoid DNA arrays. Chromosomal size DNA was isolated from transformants, expose to a low dose of gamma-rays, separated by CHEF and blot hybridized with alphoid DNA probe. Strong signals at the positions of the starting wells correspond to large circular DNA molecules. The leading bands correspond to molecules linearized by the radiation.](1471-2164-4-16-3){#F3}

###### 

Isolation of the mouse transgene Tg.AC and the human *HPRT*gene with *ARS*-containing TAR vectors

  **Targeted region**     **Experiment**   **Mean No. of transformants per ug vector (range)**   **No. of gene-positive clones/No. of clones analyzed (%)**
  ----------------------- ---------------- ----------------------------------------------------- ------------------------------------------------------------
  Tg.AC mouse transgene   1                86 (60--120)                                          3/250 (1.2)
                          2                319 (242--380)                                        2/400 (0.5)
                          3                99 (52--166)                                          3/300 (1.0)
                          Control\*        1,910 (1,132--8,600)                                  0/3000 (0.0)
  Human *HPRT*            1                72 (52--108)                                          1/300 (0.33)
                          2                24 (10--60)                                           1/150 (0.67)
                          3                22 (8--38)                                            1/175 (0.57)

\*Control TAR cloning experiment was carried out with the same TAR vector but transformants were selected on SD medium lacking 5-FOA

Because the human genome contains approximately 250,000 copies of alphoid DNA monomer, it is possible that alphoid DNA could be cloned into an *ARS*-containing vector even without counter-selection. To test this conjecture, we performed TAR cloning as above but selected His^+^, rather than the His^+^Ura^-^, transformants. As expected, the number of transformants was roughly one order of magnitude higher than that obtained with counter-selection (Table [4](#T4){ref-type="table"}). Dot-hybridization of transformants showed that approximately 3% of the clones were alphoid DNA-positive. Thus, although alphoid DNA arrays represent a significant fraction of the genome, TAR cloning of those regions is inefficient without counter-selection. Similar results were obtained during cloning of genomic fragments using the *Alu*-containing vector pARS-Alu90 (data not shown).

In conclusion, the results demonstrate that our novel selection system is useful for isolation of large centromeric regions that are poorly clonable in bacterial artificial chromosome vectors \[[@B22]\].

Discussion
==========

Over a decade ago, Furter-Graves and Hall \[[@B20]\] demonstrated that the *S. pombe ADH1*gene promoter is tolerant to insertion of up to 125 base pairs between the TATA box and the transcription start site. That observation led to the development of a system for investigating the expansion of trinucleotide repeats in yeast in which the promoter is combined with the *URA3*gene, a widely used counter-selectable marker \[[@B19],[@B23]\]. In our work, we took advantage of the specific spacing requirements of the *ADH1*promoter to develop a novel TAR cloning procedure that allows isolation of genomic regions that lack *ARS*elements. A prerequisite for development of the system was an estimate of the minimal size of targeting hooks required for TAR cloning. That size (60 bp for each hook) exactly matches the maximal size of an insert tolerated with the *ADH1*promoter. The use of the system allowed us to include a yeast origin of replication into the TAR vector and to select TAR cloning events against vector recircularization.

The new system greatly expands the applicability of TAR cloning. It eliminates the limitation of the previously described TAR cloning protocols by eliminating the need for an *ARS*sequence in the region to be cloned. Now, any region of a complex genome can be selectively isolated in yeast. Because TAR cloning produces multiple gene isolates, it allows the isolation of both parental alleles of the gene which can then be used for haplotype analysis \[[@B24]\]. Recently we found that up to 15% DNA divergence does not preclude efficient gene isolation by TAR \[[@B25]\]. Such tolerance to DNA divergence allows the isolation of highly polymorphic alleles and gene and homologues with the same TAR vector. Moreover, the new system provides an alternative approach to selectively clone large fragments of bacterial genomes \[[@B18]\] that are poor in sequences that can function as *ARS*s in yeast \[[@B14]\].

The new TAR cloning system has several potential applications for the Human Genome Project. The goal of the current phase of the Project is to close gaps and improve the quality of the data, which is to be accomplished by collecting additional sequence data. With TAR cloning, the desired regions could be isolated from the genome directly, rather than through construction and screening of new bacterial artificial chromosome libraries. Recently we successfully applied this approach to close the gaps in the draft of human genome sequence \[[@B26]\]. Characterization of the TAR isolates has shown that the gap sequences to be toxic to *E. coli*, which may explain why those regions were not found in bacterial artificial chromosome libraries. Verification of contig assembly includes characterization of multiple, independently isolated chromosome-specific clones. TAR cloning may be the simplest way to achieve that goal. We previously demonstrated that *Alu*-containing TAR cloning vectors that lack *ARS*elements are efficient for selective isolation of human DNA from human-rodent monochromosomal hybrid cell lines \[[@B27]\]. Our new counter-selectable system allows construction of representative chromosome-specific libraries. One of such library for chromosome 19 has been constructed in our laboratory and is now being used to improve the accuracy of chromosome 19 draft sequences.

Among the other advantages of the new TAR cloning system is its ability to isolate centromeric and telomeric regions, which have been generally excluded as potential targets by the Human Genome Project because of the difficulty of cloning large blocks of repetitive DNA. When centromeric DNA is digested by a restriction endonuclease, the resulting fragments are usually either too small or too large for efficient cloning in bacterial artificial chromosomes \[[@B22]\]. In recent work we reported isolation of human centromeric DNA using a TAR vector lacking *ARS*element \[[@B28]\]. While the isolation was selective, a standard TAR cloning technique does not allow to recover a significant fraction of alphoid DNA arrays that does not contain *ARS*. In our present study, using the new TAR cloning strategy clones of human alphoid DNA up to \~ 210 kb in length were isolated with high selectivity. Most of the TAR clones contained exclusively alphoid DNA, which in some cases was organized in higher-order repeat arrays (data not shown). Approximately 15% of the isolates contained alphoid DNA arrays interrupted with nonalphoid DNA sequences, including *Alu*and *LINE*repeats. Those clones can be used as starting material for construction of physical maps of human centromeres as well as for functional analysis of centromeres.

Methods
=======

Yeast strains, transformation, and selection of gene-positive clones
--------------------------------------------------------------------

The highly transformable *S. cerevisiae*strain VL6-48N (*MATalpha, his3-Δ200, trp1-Δ1*, *ura3-Δ1*, *lys2*, *ade2-101, met14*), which has *HIS3*and *URA3*deletions, was used for transformation. The strain is a derivative of VL6-48 with the *ura3-52*gene replaced by the *KanMX*cassette \[[@B15]\]. Spheroplasts were generated as described previously \[[@B29]\]. Agarose plugs (60 ul) containing approximately 2 ug of high molecular weight DNA were prepared from normal human fibroblasts MRC-5 (ATCC) or from liver cells of the Tg.AC mouse \[[@B11]\]. Linearized TAR cloning vector (1 ug) was added to the plugs, treated with agarase, and mixed with yeast spheroplasts. Optimum conditions for TAR cloning have been recently described \[[@B30]\]. Transformants were selected on synthetic histidine-minus plates containing 5-fluoroorotic acid (5-FOA) to select clones that no longer express *URA3*\[[@B31]\]. Because of its toxic effect on yeast spheroplasts, 5-FOA was not included in the top agar.

Construction of TAR vectors
---------------------------

Table [1](#T1){ref-type="table"} lists the TAR cloning vectors used in this study. All those vectors were created with the Bluescript-based yeast-*E. coli*shuttle vector pRS313 *(HIS3-CEN6-ARSH4)*\[[@B32]\]. The cassette containing the *URA3*gene driven by the *Shizosaccharomyces pombe ADH1*promoter was derived from the pBL94 plasmid \[[@B19]\]. In the original cassette, the *ADH1*promoter and *URA3*were separated by a 35-bp adaptor containing an out-of-frame ATG initiation codon. In our construct, we deleted this adaptor to prevent use of the start codon for translation; that would result in nonexpression of the functional *URA3*gene and, therefore, an inability to grow in the absence of uracil. The deletion of the adaptor also provided an opportunity to incorporate longer DNA fragments between the TATA box and the transcription initiation site without inactivation of *URA3*. Construction of the modified *ADH1-URA3*cassette included PCR amplification of the *ADH1*promoter and the *URA3*gene from the pBL94 plasmid using two pairs of primers, ADH-F plus ADH-R and URA-ARS-F plus URA-ARS-R (Table [2](#T2){ref-type="table"}). The first pair amplifies the *ADH1*promoter as an *Apa*I-*Xho*I fragment; the second amplifies the *URA3*gene as a *Cla*I-*Bam*HI fragment. The PCR fragments were inserted into a pRS313 polylinker \[[@B32]\] to generate the basic *ARS*-containing TAR vector designated as pARS-VN. In this vector, the TATA box and the initiation transcription site in *URA3*are separated by *Xho*I-*Cla*I sites, which were used to clone targeting hooks.

###### 

Selective cloning of alphoid DNA arrays from human genome with a *ARS*-containing TAR vector

  **Transformant selection medium**   **Genomic DNA in transformation mix**   **Number of transformants per ug vector (range)**   **Yield of clones with alphoid DNA arrays (%)**
  ----------------------------------- --------------------------------------- --------------------------------------------------- -------------------------------------------------
  SD-His^-^FoA\*                      no                                      5 (2--7)                                            N/A
  SD-His^-^                           no                                      2,095 (1,930--2,270)                                N/A
  SD-His^-^FoA                        yes                                     245 (188--380)                                      50.0
  SD-His^-^                           yes                                     9,225 (8,560--9,620)                                3.5

Transformants were selected on either synthetic (SD) histidine minus or histidine minus plates containing 5-fluoroorotate (5-FOA) to select clones that had lost the *URA3*marker. 5-FOA was excluded from top agar because of its toxic effect on yeast spheroplasts regeneration.

To determine the distance permitted between the TATA box and the transcription initiation site in pARS-VN, we cloned different sized *Alu*targeting hooks (45/45 bp, 45/65 bp, 45/75 bp, 65/65 bp, 75/75 bp, and 115/75 bp) into vector *Xho*I-*Cla*I sites. The *Alu*hooks were PCR-amplified from the 3\' end of a 290-bp *Alu*consensus sequence \[[@B33]\] with pairs of alu-F, alu-R primers (Table [2](#T2){ref-type="table"}). Each pair of *Alu*targeting hooks is separated by a *Sma*I site present in the *Alu*consensus sequence. Six constructs -- pARS-Alu90, pARS-Alu110, pARS-Alu120, pARS-Alu130, pARS-Alu150, and pARS-Alu190 -- with different sized *Alu*sequences (from 90 bp to 190 bp) were tested for *URA3*expression after transformation into VL6-48N. Expression of *URA3*(determined by the sensitivity of His^+^transformants to 5-FOA) was abolished with 150-bp and 190-bp *Alu*inserts. Based on those results, we concluded that targeting sequences (hooks) with a combined length of up to 130 bp cloned into the *ADH1*promoter region would allow selection for insertion events during TAR cloning.

We designed three pairs of targeting hooks to investigate the selectivity of the new TAR cloning system. The first pair contained 60 bp of the SV40-specific targeting sequence in the Tg.AC transgene \[[@B5],[@B11]\] and 50 bp of the mouse *B1*element. The hooks were PCR-amplified from the SV800 vector using specific primer pairs SV-ARS-F and SV-ARS-R (Table [2](#T2){ref-type="table"}) and cloned into *Xho*I-*Cla*I sites of pARS-VN, yielding the vector pARS-TGAC. We mutated an out-of-frame ATG codon identified in a *B1*template sequence during PCR amplification of the hook to avoid translational incompetence and resistance to 5-FOA. The second pair contained 56-bp and 60-bp specific sequences from the 5\' and 3\' ends of human *HPRT*. The hooks were amplified from *HPRT*yeast artificial chromosome (YAC) \[[@B6]\] with primer pairs HP-ARS-F and HP-ARS-R (Table [2](#T2){ref-type="table"}) and cloned into the *Xho*I-*Cla*I sites of pARS-NK, yielding the vector pARS-HPRT. The third vector, pARS-ALF, was designed for cloning human alphoid DNA arrays. pARS-ALF contained two 40-bp fragments of alphoid DNA monomer that were PCR-amplified using the primer pair ALF-F and ALF-R from a 171-bp alphoid consensus sequence (X07685) \[[@B34]\]. None of the amplified targeting hooks contained an ATG codon that was out-of-frame in *URA3*. Vectors pARS-TGAC and pARS-HPRT were linearized by *Sal*I, pARS-Alu by *Sma*I, and pARS-ALF by *Mlu*I, exposing the targeting sequences. The TAR vector pARS-SV211-URA was constructed by insertion of the *S. cerevisiae URA3*gene between the targeting hooks of pVC-SV211 \[[@B7]\] and cloning of *ARSH4*into the polylinker. *URA3*was amplified as a \~ 1.1 kb fragment from pRS306 \[[@B32]\]. Before TAR cloning, the vector was linearized with *Bam*HI to expose the *B1*targeting sequence and the *URA3*sequence placed at the end of the transgene-specific hook.

Three TAR vectors used in this study did not contain *ARS*elements. Two of them, pVC-SV211 and pVC-SV60, contain a 130-bp mouse *B1*element as a common hook and, respectively, 211 bp and 60 bp of the trangene-specific targeting hooks. These vectors have been described \[[@B7]\]. We constructed an additional vector to investigate how the presence of nonhomologous DNA at the end of a hook affects the efficiency of gene capture. The pVC-SV60-polylinker plasmid contains the same hooks as pVC-SV60 \[[@B7]\], but the hooks are separated by approximately 70 bp in the pBluscript polylinker. This configuration allowed us to linearize the vector by a different combination of enzymes, producing a set of TAR constructs with different lengths of nonhomologous DNA at the end of the specific hook (Fig. [1](#F1){ref-type="fig"}).

Detection of positive clones among yeast transformants
------------------------------------------------------

We used two pairs of primers to identify transformants containing a human *HPRT*sequence. IN1R plus IN1L amply a 516-bp sequence in intron 1, and 46L plus 47R amplify a 575-bp sequence in exon 2, along with flanking introns \[[@B15]\]. We used a pair of primers specific to the zeta-globin promoter region to screen PCR transformants for the Tg.AC transgene sequence \[[@B7]\]. These primers generate a 419-bp PCR product that is diagnostic for recombination between the TAR vector and genomic Tg.AC transgene sequences. Yeast genomic DNA was isolated from transformants and PCR-amplified as described previously \[[@B29]\].

Detection of recombinant clones obtained during TAR cloning with *Alu*- and alphoid DNA-containing vectors was carried out by colony hybridization. For this purpose, we designed two specific probes -- a 56-bp alphoid DNA fragment (*Sat*-probe) and a 124-bp *Alu*fragment (*Alu*-probe). Because those sequences are not present in the TAR constructs, they are diagnostic for recombinant clones. The probes were labeled for hybridization by PCR using *Alu*and alphoid DNA monomers as templates and repeat-specific primers (Table [2](#T2){ref-type="table"}).

Characterization of YAC clones
------------------------------

Chromosome-size DNA was prepared from yeast transformants carrying circular YACs, separated by clamped homogeneous electrical field gel electrophoresis (CHEF), transferred onto a nylon membrane, and hybridized with an alphoid DNA probe or *Alu*-probe (see above). The size of circular YACs was estimated by melting the agarose plugs with yeast genomic DNA prior to CHEF analysis. This treatment linearized approximately 20% of the YACs in the 100--400 kb size range. Southern blot analysis of YAC DNA was performed with ^32^P labeled probes and the protocol described by Church and Gilbert \[[@B35]\].

Abbreviations
=============

*ARS*, autonomously replicating sequence; 5-FOA, 5-fluoroorotic acid; TAR, transformation-associated recombination; YAC, yeast artificial chromosome.
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